The cumulative risk of a false-positive recall in the Norwegian Breast Cancer Screening Program

Cancer
Solveig HofvindSteinar Tretli

Abstract

Biennial breast cancer screening for women ages 50-69 years is recommended by the World Health Organization. It has been claimed that the cumulative risk of a false-positive recall is a significant disadvantage in breast cancer screening programs. The primary objective of this study was to estimate the cumulative risk of a false-positive recall during a screening period of 20 years in women ages 50-51 years who are screened biennially in a population-based screening program. A secondary objective was to estimate the cumulative risk of undergoing fine-needle aspiration cytology, core needle biopsy, and open biopsy with benign morphology in the same group of women. The Norwegian Breast Cancer Screening Program invites all women ages 50-69 years who reside in the country to a 2-view mammography biennially. A nationwide data base that covers all of the invited women includes individual information about all screening activity. Results from three screening rounds in four counties were the basis for this study. False-positive recalls due to abnormal mammograms among 83,416 women who participated all the 3 screening rounds were the basis for the estimations. It was calculated that women ages 50-51 years who participate in biennial scr...Continue Reading

References

Mar 1, 1992·AJR. American Journal of Roentgenology·D B Kopans
Sep 1, 1989·Annals of Internal Medicine·D M Eddy
Apr 17, 1998·The New England Journal of Medicine·J G ElmoreS W Fletcher
Jan 1, 1997·Journal of the National Cancer Institute. Monographs·B K Rimer, L G Bluman
Aug 26, 1998·The New England Journal of Medicine·I A OlivottoA J Coldman
Oct 19, 2000·Journal of the National Cancer Institute·C L ChristiansenS W Fletcher
Feb 13, 2001·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·N M Perry, UNKNOWN EUSOMA Working Party
Mar 27, 2001·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·C LampicP O Sjödén
Aug 23, 2001·AJR. American Journal of Roentgenology·B C YankaskasR Kozar
Sep 12, 2002·Breast Cancer Research : BCR·Jenny McCannSara Godward
May 3, 2003·Lancet·Suzie J OttoUNKNOWN National Evaluation Team for Breast Cancer Screening
Jul 5, 2003·BMC Medical Research Methodology·Stuart G BakerBarnett S Kramer
Oct 23, 2003·JAMA : the Journal of the American Medical Association·Rebecca Smith-BindmanKarla Kerlikowske
Feb 18, 2004·The Breast : Official Journal of the European Society of Mastology·Ø EkebergR Kåresen

❮ Previous
Next ❯

Citations

Jun 7, 2011·European Radiology·Raquel Zubizarreta AlberdiUNKNOWN CFPR (Cumulative False Positive Risk) group(1)
Sep 9, 2011·European Radiology·Nieves AscunceUNKNOWN Cumulative False Positive Risk (CFPR) Group
Jun 15, 2012·European Radiology·Wikke Setz-PelsAdri C Voogd
Nov 26, 2010·Current Oncology Reports·Bradford R Hirsch, Gary H Lyman
Oct 8, 2011·Health Care for Women International·Marit SolbjørAnn Rudinow Sætnan
Mar 25, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·R RománX Castells
Jun 24, 2011·Epidemiologic Reviews·Suzanne W Fletcher
Apr 12, 2012·Journal of the National Cancer Institute·My von Euler-ChelpinIlse Vejborg
Feb 3, 2005·American Journal of Clinical Oncology·Blake Cady, Maureen Chung
Oct 28, 2010·Current Opinion in Obstetrics & Gynecology·Kimberly D Gregory, George F Sawaya
Sep 15, 2010·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Louise E JohnsUNKNOWN Age Trial Management Group
Apr 2, 2010·Statistical Methods in Medical Research·Rebecca A HubbardRobert A Smith
Mar 20, 2013·Annals of Family Medicine·John Brodersen, Volkert Dirk Siersma
May 13, 2009·Annals of Family Medicine·Jennifer Miller CroswellRobert E Schoen
Nov 19, 2009·Annals of Internal Medicine·Heidi D NelsonUNKNOWN U.S. Preventive Services Task Force
Sep 28, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S H Njor, M von Euler-Chelpin
Jun 22, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J D M OttenA L M Verbeek
May 14, 2014·Japanese Journal of Clinical Oncology·Akihiko SuzukiNoriaki Ohuchi
Nov 13, 2012·Cancer Epidemiology·X CastellsUNKNOWN Cumulative False Positive Risk Group
May 28, 2011·Breast Cancer Research and Treatment·R RománX Castells
Dec 17, 2009·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·Sven TörnbergAntonio Ponti
Feb 16, 2016·Radiology·Xavier CastellsUNKNOWN BELE Study Group
Dec 21, 2012·American Journal of Preventive Medicine·Katrina ArmstrongMirar N Bristol Demeter
Jun 11, 2011·Preventive Medicine·Paul Glasziou, Nehmat Houssami
May 18, 2011·Preventive Medicine·Dolores SalasUNKNOWN CFPR (Cumulative False Positive Risk) group
May 28, 2015·Cancer Epidemiology·Katja Kemp JacobsenSisse Helle Njor
Jul 21, 2009·Primary Care·Jeffrey A Tice, Karla Kerlikowske
Jan 28, 2009·Scandinavian Journal of Caring Sciences·Bjørg Hafslund, Monica W Nortvedt
Jun 16, 2009·Journal of Evaluation in Clinical Practice·Eric ChamotThomas V Perneger
Dec 10, 2008·International Journal of Cancer. Journal International Du Cancer·Karl J SweeneyMichael J Kerin
Jun 10, 2011·The British Journal of Surgery·A F W van der SteegJ A Roukema
Jan 11, 2005·Lancet·Suzanne W Fletcher, Joann G Elmore
Jul 30, 2015·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Valerie JenkinsVernon Farewell
May 22, 2016·Japanese Journal of Clinical Oncology·Chisato HamashimaUNKNOWN Japanese Research Group for the Development of Breast Cancer Screening Guidelines

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.